AR030410A1 - Derivados de 2-fenilpiran-4-ona, proceso para obtener dichos derivados, composiciones farmaceuticas que comprenden los derivados mencionados y el uso de los mismos en la manufactura de medicamentos - Google Patents
Derivados de 2-fenilpiran-4-ona, proceso para obtener dichos derivados, composiciones farmaceuticas que comprenden los derivados mencionados y el uso de los mismos en la manufactura de medicamentosInfo
- Publication number
- AR030410A1 AR030410A1 ARP010101221A ARP010101221A AR030410A1 AR 030410 A1 AR030410 A1 AR 030410A1 AR P010101221 A ARP010101221 A AR P010101221A AR P010101221 A ARP010101221 A AR P010101221A AR 030410 A1 AR030410 A1 AR 030410A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkyl
- derivatives
- compounds
- atom
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/38—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms one oxygen atom in position 2 or 4, e.g. pyrones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
Abstract
Se describen y reivindican compuestos de 2-(4-sulfonilfenil)-piran-4-ona de la formula general 1 y sales farmacéuticamente aceptables de dichos compuestos, representando en dicha formula: R1 un grupo alquilo o un grupo -NR5R6, donde R5 y R6, cada uno independientemente, representan un átomo de hidrogeno o un grupo alquilo; R2 un grupo alquilo, C3-7cicloalquilo, piridilo, tienilo, naftilo, tetrahidronaftilo o indanilo, o un grupo fenilo, el cual puede ser no sustituido o sustituido por al menos un átomo de halogeno o grupos alquilo, trifluorometilo, hidroxi, alcoxi, metiltio, amino, mono- o di-alquiamino, hidroxialquilo o hidroxicarbonilo; R3 un grupo alquilo, hidroximetilo, alcoximetilo, alqueniloximetilo, C3-7cicloalcoximetilo, C3-7cicloalquilmetoximetilo, benciloximetilo, hidroxicarbonilo, nitrilo, trifluorometilo o difluorometilo o un grupo R7-COO-CH2-, donde R7 representa un grupo alquilo o un grupo fenilo; R4 un átomo de hidrogeno, o un grupo alquilo, alquenilo o alquinilo, o un átomo de halogeno; y X un enlace simple, un átomo de oxígeno, un átomo de azufre o un grupo metileno; o sales farmacéuticamente aceptables de los mismos. También se reivindican procesos para preparar dichos compuestos, composiciones farmacéuticas que contienen dichos compuestos y el uso médico de los mismos, incluyendo el uso de los mismos en la preparacion de medicamentos para tratar enfermedades, estados febriles o inflamatorios, inhibiendo la produccion de prostanoides inducida por el tejido muscular liso, contracciones o para prevenir el tratamiento del cáncer colonrectal o enfermedades degenerativas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200000637 | 2000-03-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR030410A1 true AR030410A1 (es) | 2003-08-20 |
Family
ID=8492732
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP010101221A AR030410A1 (es) | 2000-03-16 | 2001-03-15 | Derivados de 2-fenilpiran-4-ona, proceso para obtener dichos derivados, composiciones farmaceuticas que comprenden los derivados mencionados y el uso de los mismos en la manufactura de medicamentos |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7354936B2 (es) |
| EP (1) | EP1263751B1 (es) |
| JP (1) | JP2003527389A (es) |
| KR (1) | KR20030005221A (es) |
| CN (1) | CN1429221A (es) |
| AR (1) | AR030410A1 (es) |
| AT (1) | ATE269316T1 (es) |
| AU (1) | AU2001254692A1 (es) |
| BG (1) | BG107101A (es) |
| BR (1) | BR0109252A (es) |
| CA (1) | CA2403149A1 (es) |
| CZ (1) | CZ20023058A3 (es) |
| DE (1) | DE60103859T2 (es) |
| EE (1) | EE200200528A (es) |
| ES (1) | ES2223830T3 (es) |
| HK (1) | HK1048117A1 (es) |
| HU (1) | HUP0301696A2 (es) |
| IL (1) | IL151598A0 (es) |
| MX (1) | MXPA02009016A (es) |
| NO (1) | NO20024393L (es) |
| NZ (1) | NZ521187A (es) |
| PE (1) | PE20011333A1 (es) |
| PL (1) | PL358062A1 (es) |
| RU (1) | RU2002127728A (es) |
| SK (1) | SK12832002A3 (es) |
| WO (1) | WO2001068633A1 (es) |
| ZA (1) | ZA200207184B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6465509B2 (en) | 2000-06-30 | 2002-10-15 | Merck Frosst Canada & Co. | Pyrones as inhibitors of cyclooxygenase-2 |
| ES2213485B1 (es) | 2003-02-13 | 2005-12-16 | Almirall Prodesfarma, S.A. | Derivados de la 2-fenilpiran-4-ona. |
| CN102731456B (zh) * | 2011-04-01 | 2014-07-09 | 华中科技大学 | 一种抗肿瘤化合物及其制备方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH523257A (de) | 1969-12-31 | 1972-05-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Imidazolderivaten |
| US3901908A (en) | 1970-12-28 | 1975-08-26 | Ciba Geigy Corp | 2-alkyl- and 2-cycloalkyl-4,5-bis-phenyl-imidazoles |
| US4304728A (en) | 1979-04-05 | 1981-12-08 | Lilly Industries Limited | 6-Substituted pyranone compounds and their use as pharmaceuticals |
| IL59748A (en) | 1979-04-05 | 1983-11-30 | Lilly Industries Ltd | 5-substituted pyranone derivatives,their production and pharmaceutical compositions containing them |
| US6048850A (en) | 1992-09-22 | 2000-04-11 | Young; Donald A. | Method of inhibiting prostaglandin synthesis in a human host |
| EP0729466A1 (en) * | 1993-11-19 | 1996-09-04 | PARKE, DAVIS & COMPANY | Pyrone derivatives as protease inhibitors and antiviral agents |
| US5521213A (en) | 1994-08-29 | 1996-05-28 | Merck Frosst Canada, Inc. | Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 |
| US5541204A (en) | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
| WO1996031509A1 (en) | 1995-04-04 | 1996-10-10 | Glaxo Group Limited | IMIDAZO[1,2-a]PYRIDINE DERIVATIVES |
| MXPA00004955A (es) | 1997-11-19 | 2002-10-17 | Kowa Co | Derivados novedosos de piridazina y medicinas que los contienen como ingredientes activos. |
| TW587079B (en) * | 1998-09-25 | 2004-05-11 | Almirall Prodesfarma Ag | 2-phenylpyran-4-one derivatives |
-
2001
- 2001-03-13 PE PE2001000241A patent/PE20011333A1/es not_active Application Discontinuation
- 2001-03-15 AR ARP010101221A patent/AR030410A1/es not_active Application Discontinuation
- 2001-03-16 CA CA002403149A patent/CA2403149A1/en not_active Abandoned
- 2001-03-16 KR KR1020027011875A patent/KR20030005221A/ko not_active Application Discontinuation
- 2001-03-16 MX MXPA02009016A patent/MXPA02009016A/es unknown
- 2001-03-16 CZ CZ20023058A patent/CZ20023058A3/cs unknown
- 2001-03-16 NZ NZ521187A patent/NZ521187A/en unknown
- 2001-03-16 PL PL01358062A patent/PL358062A1/xx not_active Application Discontinuation
- 2001-03-16 AU AU2001254692A patent/AU2001254692A1/en not_active Abandoned
- 2001-03-16 SK SK1283-2002A patent/SK12832002A3/sk unknown
- 2001-03-16 CN CN01809447A patent/CN1429221A/zh active Pending
- 2001-03-16 JP JP2001567725A patent/JP2003527389A/ja not_active Withdrawn
- 2001-03-16 ES ES01927742T patent/ES2223830T3/es not_active Expired - Lifetime
- 2001-03-16 EE EEP200200528A patent/EE200200528A/xx unknown
- 2001-03-16 WO PCT/EP2001/003042 patent/WO2001068633A1/en active IP Right Grant
- 2001-03-16 AT AT01927742T patent/ATE269316T1/de not_active IP Right Cessation
- 2001-03-16 IL IL15159801A patent/IL151598A0/xx unknown
- 2001-03-16 EP EP01927742A patent/EP1263751B1/en not_active Expired - Lifetime
- 2001-03-16 RU RU2002127728/04A patent/RU2002127728A/ru not_active Application Discontinuation
- 2001-03-16 HU HU0301696A patent/HUP0301696A2/hu unknown
- 2001-03-16 DE DE60103859T patent/DE60103859T2/de not_active Expired - Lifetime
- 2001-03-16 BR BR0109252-9A patent/BR0109252A/pt not_active IP Right Cessation
-
2002
- 2002-09-06 ZA ZA200207184A patent/ZA200207184B/en unknown
- 2002-09-13 NO NO20024393A patent/NO20024393L/no not_active Application Discontinuation
- 2002-09-13 BG BG107101A patent/BG107101A/bg unknown
- 2002-09-16 US US10/245,873 patent/US7354936B2/en not_active Expired - Fee Related
-
2003
- 2003-01-11 HK HK03100285.1A patent/HK1048117A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20030232880A1 (en) | 2003-12-18 |
| PL358062A1 (en) | 2004-08-09 |
| WO2001068633A1 (en) | 2001-09-20 |
| RU2002127728A (ru) | 2004-03-20 |
| EP1263751B1 (en) | 2004-06-16 |
| ZA200207184B (en) | 2003-12-08 |
| CN1429221A (zh) | 2003-07-09 |
| CA2403149A1 (en) | 2001-09-20 |
| EP1263751A1 (en) | 2002-12-11 |
| JP2003527389A (ja) | 2003-09-16 |
| US7354936B2 (en) | 2008-04-08 |
| NZ521187A (en) | 2004-03-26 |
| DE60103859D1 (de) | 2004-07-22 |
| BR0109252A (pt) | 2002-12-24 |
| BG107101A (bg) | 2003-07-31 |
| HK1048117A1 (zh) | 2003-03-21 |
| IL151598A0 (en) | 2003-04-10 |
| CZ20023058A3 (cs) | 2004-01-14 |
| HUP0301696A2 (hu) | 2003-09-29 |
| MXPA02009016A (es) | 2004-10-15 |
| SK12832002A3 (sk) | 2003-11-04 |
| PE20011333A1 (es) | 2002-01-16 |
| NO20024393L (no) | 2002-11-13 |
| NO20024393D0 (no) | 2002-09-13 |
| AU2001254692A1 (en) | 2001-09-24 |
| KR20030005221A (ko) | 2003-01-17 |
| ATE269316T1 (de) | 2004-07-15 |
| DE60103859T2 (de) | 2005-07-21 |
| EE200200528A (et) | 2004-04-15 |
| ES2223830T3 (es) | 2005-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0416212A (pt) | derivado de piridazinona, composição farmacêutica, uso do derivado, método para o tratamento de um sujeito afligido com uma condição ou doença susceptìvel de melhora pela inibição de fosfodiesterase 4 e produto de combinação | |
| RU2006130000A (ru) | Органические соединения | |
| AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
| HUP0300798A2 (hu) | Szubsztituált triazolopirimidin-származékok és alkalmazásuk rákellenes hatóanyagként és ezeket tartalmazó gyógyszerkészítmények | |
| MXPA04009784A (es) | Tiazolidin-4-carbonitrilos y analogos y su uso como inhibidores de dipeptidil-peptidas. | |
| BR0214989A (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento de doenças, e, processo para a preparação de um composto | |
| HUP0300894A2 (hu) | Szubsztituált béta-karbolinok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| NO20060974L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| HUP0303876A2 (hu) | 2 Típusú diabétesz kezelésére alkalmas gyógyszerkészítmény előállítása dipeptidil-peptidáz IV inhibitor hatású piperidin vagy tiazolidinszármazékok alkalmazásával | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| ATE397605T1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| NO20072116L (no) | Farmasoytiske forbindelser | |
| BRPI0514509A (pt) | uso de composto n-aril diazaespiracìclicos no tratamento de dependência | |
| NO331166B1 (no) | Inhibitorer av tyrosinkinaser, fremgangsmate for fremstilling derav, farmasoytisk preparat samt anvendelse av forbindelsene | |
| GB0226724D0 (en) | Therapeutic agents | |
| NO20070378L (no) | Bis(tio-hydrazidamid)-salter for behandling av kreft | |
| EA200701780A1 (ru) | Противоопухолевое средство | |
| MX2007004248A (es) | Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa. | |
| EA200300333A1 (ru) | Новые тиадиазолы и оксадиазолы и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
| JP2005537323A5 (es) | ||
| ATE372995T1 (de) | Benzo(b)(1,4)dioxepinderivate | |
| MD3609886T2 (ro) | Analogi de benzoazepină ca agenți de inhibare pentru tirozin kinaza Bruton | |
| NO20085271L (no) | Muscarin reseptoragonister som er effektive i behandling av smerte, Alzheimers sykdom og schizofreni | |
| BG105373A (en) | 2-phenylpyran-4-one derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |